Lataa...
Fentanyl for the Treatment of Tumor-Related Breakthrough Pain
BACKGROUND: Breakthrough cancer pain (BTCP) is common among cancer patients and markedly lowers their quality of life. The treatment for BTCP episodes that is recommended in current guidelines involves extended-release formulations in combination with rapid-onset and short-acting opioids. In the pas...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Deutscher Arzte Verlag
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3648890/ https://ncbi.nlm.nih.gov/pubmed/23671467 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3238/arztebl.2013.0271 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|